88 related articles for article (PubMed ID: 19708576)
1. [First experience of using modified program NHL-BFM-90 for the treatment of primary diffuse large-B-cell lymphosarcoma of the bones and soft tissues with poor-prognosis].
Morozova AK; Zvonkov EE; Kremenetskaia AM; Magomedova AU; Obukhova TN; Mamonov VE; Bariakh EA; Gubkin AV; Lukina AI; Iliushkina EA; Fink OS; Perestoronina TN; Kravchenko SK
Ter Arkh; 2009; 81(7):61-5. PubMed ID: 19708576
[TBL] [Abstract][Full Text] [Related]
2. [First experience with the modified program NHL-BFM-90 application in adult patients with primary diffuse large B-cell gastric lymphosarcoma with unfavourable prognosis].
Zvonkov EE; Krasil'nikova BB; Makhinia VA; Kaplanskaia IB; Kravchenko SK; Karagiulian SR; Grzhimolovskiĭ AV; Kuznetsov AN; Magomedova AU; Shukhman IM; Bariakh EA; Giliazitdinova EA; Gubkin AV; Lorie IuIu; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2006; 78(7):38-46. PubMed ID: 16944749
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of conservative treatment of gastric lymphosarcoma].
Zvonkov EE; Kremenetskaia AM; Kravchenko SK; Makhinia VA; Kaplanskaia IB; Obukhova TN; Samoĭlova RS; Shevelev AA; Magomedova AU; Bariakh EA; Krasil'nikova BB; Gubkin AV; Iliushkina EA; Mar'in DS; Morozova AK; Kulikov SM; Gemdzhian EG; Vorob'ev AI
Ter Arkh; 2008; 80(7):18-26. PubMed ID: 18763589
[TBL] [Abstract][Full Text] [Related]
4. [Nine-year experience in the treatment of patients with diffuse large B-cell lymphosarcoma].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EA; Bariakh EA; Mangasarova IaK; Kaplanskaia IB; Samoĭlova RS; Vorob'ev IA; Obukhova TN; Karagiulian SR; Shulutko EM; Galstian GM; Mar'in DS; Gabeeva NG; Vorob'ev AI
Ter Arkh; 2011; 83(7):5-10. PubMed ID: 21894745
[TBL] [Abstract][Full Text] [Related]
5. [Primary lymphomas of bones and soft tissues: comparative assessment of treatment results].
Morozova AK; Zvonkov EE; Mamonov VE; Kremenetskaia AM; Kravchenko SK; Tseĭtlina MA; Stroiakovskiĭ DL; Bapiakh EA; Magomedova AU; Obukhova TN; Kaplanov KD; Pustovoĭt LA; Lukina AI; Gemdzhian ÉG; Egorova EK; Pen'kov MIu; Vorob'ev AI
Ter Arkh; 2012; 84(7):42-9. PubMed ID: 23038971
[TBL] [Abstract][Full Text] [Related]
6. [First experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary skin involvement. A case report].
Zamiatina VI; Magomedova AU; Kravchenko SK; Giliazitdinova EA; Iliushkina EA; Zvonkov EE; Kaplanskaia IB; Obukhova TN; Kliasova GA; Gorgidze LA; Churakova ZhV; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2009; 81(7):71-5. PubMed ID: 19708578
[TBL] [Abstract][Full Text] [Related]
7. [The modified program NHL-BFM-90 in the treatment of patients with diffuse large B-cell lymphosarcoma].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EE; Bariakh EA; Margolin OV; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Obukhova TN; Moiseeva TN; Zybunova EE; Gemdzhian EG; Vorob'ev AI
Ter Arkh; 2006; 78(10):44-7. PubMed ID: 17180937
[TBL] [Abstract][Full Text] [Related]
8. [Primary diffuse large B-cell lymphosarcoma of the spleen].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Kaplanskaia IB; Zybunova EE; Samoĭlova RS; Vorob'ev IA; Obukhova TN; Ryzhko VV; Zvonkov EE; Vorob'ev AI
Ter Arkh; 2007; 79(7):62-6. PubMed ID: 17802793
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
[TBL] [Abstract][Full Text] [Related]
11. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
12. [International prognostic index in diffuse B large cell lymphosarcoma].
Magomedova AU; Vorob'ev AI
Ter Arkh; 2008; 80(3):71-6. PubMed ID: 18441690
[TBL] [Abstract][Full Text] [Related]
13. [Eight-year experience in treating aggressive mediastinal large B-cell lymphomas].
Mangasarova IaK; Magomedova AU; Kravchenko SK; Shmakov RG; Bariakh EA; Vorob'ev VI; Mar'in DS; Skidan NI; Gemdzhian ÉG; Misiurin AV; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2013; 85(7):50-6. PubMed ID: 24137947
[TBL] [Abstract][Full Text] [Related]
14. [A CHOP-21 course efficacy in therapy of diffuse large B-cell lymphosarcoma].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Zvonkov EE; Moiseeva TN; Zybunova EE; Kaplanskaia IB; Samoĭlova RS; Vorob'ev IA; Lorie IuIu; Margolin OV; Giliazitdinova EA; Gubkin AV; Chernova NG; Ryzhko VV; Gemdzhian EG
Ter Arkh; 2005; 77(7):58-61. PubMed ID: 16116911
[TBL] [Abstract][Full Text] [Related]
15. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Seidemann K; Tiemann M; Lauterbach I; Mann G; Simonitsch I; Stankewitz K; Schrappe M; Zimmermann M; Niemeyer C; Parwaresch R; Riehm H; Reiter A;
J Clin Oncol; 2003 May; 21(9):1782-9. PubMed ID: 12721255
[TBL] [Abstract][Full Text] [Related]
16. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
Laskar S; Bahl G; Muckaden MA; Nair R; Gupta S; Bakshi A; Gujral S; Shet T; Shrivastava SK; Dinshaw KA
Cancer; 2007 Aug; 110(4):816-23. PubMed ID: 17582622
[TBL] [Abstract][Full Text] [Related]
17. [Diffuse large B-cell lymphoma with primary involvement of mediastinal lymph nodes: diagnosis and treatment].
Mangasarova IaK; Magomedova AU; Kravchenko SK; Zvonkov EE; Kremenetskaia AM; Vorob'ev VI; Mar'in DS; Gubkin AV; Skidan NI; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Vorob'ev AI
Ter Arkh; 2010; 82(7):61-5. PubMed ID: 20853612
[TBL] [Abstract][Full Text] [Related]
18. Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
Danieu L; Wong G; Koziner B; Clarkson B
Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438
[TBL] [Abstract][Full Text] [Related]
19. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens.
Villela L; López-Guillermo A; Montoto S; Rives S; Bosch F; Perales M; Ferrer A; Esteve J; Colomo L; Campo E; Montserrat E
Cancer; 2001 Apr; 91(8):1557-62. PubMed ID: 11301405
[TBL] [Abstract][Full Text] [Related]
20. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
